Status:

COMPLETED

Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Low Grade Glioma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Determine the overall discriminatory ability of FET PET in the diagnosis of glioma grade II (referring to the current diagnostic gold standard represented by the histopathology exam of a tumor sample)...

Detailed Description

Low-grade glioma is a malignant tumor of young adults (12.5% of gliomas, incidence of 0.99 / 100,000). Median survival, linked to anaplastic transformation is estimated between 7 and 10 years, with gr...

Eligibility Criteria

Inclusion

  • Patients over 18 years
  • Diagnosis of glioma grade II referred on clinical and MRI morphologic
  • Realization of a brain MRI in preoperative condition of neuronavigation (MRI sequences including axial T2, Flair, T1, T1 with gadolinium) in a within 1 month with FET PET.
  • Histological examination scheduled within one month with FET PET by resection (complete or partial) or by biopsy
  • Patients who signed informed consent
  • No against-indication for PET
  • No against-indications to MRI

Exclusion

  • Grade II glioma who have received specific treatment with radiotherapy and or chemotherapy.
  • Pregnant or breastfeeding women.
  • Weight greater than 120 Kg
  • against-indication to PET
  • against- indication gadolinium
  • Possible side effects to MRI (magnetic foreign bodies, pacemaker, congestive severe renal).)
  • Patient under guardianship
  • No coverage by social security

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT02286531

Start Date

June 1 2010

End Date

December 1 2014

Last Update

August 19 2015

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

CHU de CAEN

Caen, France, 14033

2

Hôpital de la Pitié Salpétrière

Paris, France

3

UHToulouse

Toulouse, France, 31000